The Growth Fund of America®
[photo of peaches hanging from tree branches]
Special feature
Focusing on companies that can produce now and over the long term
See page 6
Annual report for the year ended August 31, 2012
The Growth Fund of America invests in a wide range of companies that appear to offer superior opportunities for growth of capital.
This fund is one of more than 40 offered by American Funds, which is one of the nation’s largest mutual fund families. For more than 80 years, Capital Research and Management Company,SM the American Funds adviser, has invested with a long-term focus based on thorough research and attention to risk.
Fund results shown in this report, unless otherwise indicated, are for Class A shares at net asset value. If a sales charge (maximum 5.75%) had been deducted, the results would have been lower. Results are for past periods and are not predictive of results for future periods. Current and future results may be lower or higher than those shown. Share prices and returns will vary, so investors may lose money. Investing for short periods makes losses more likely. Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value. For current information and month-end results, visit americanfunds.com.
Here are the average annual total returns on a $1,000 investment with all distributions reinvested for periods ended September 30, 2012 (the most recent calendar quarter-end): |
| | | | | | | | | |
Class A shares | | 1 year | | | 5 years | | | 10 years | |
Reflecting 5.75% maximum sales charge | | | 20.57 | % | | | –1.12 | % | | | 8.08 | % |
The total annual fund operating expense ratio is 0.71% for Class A shares as of the prospectus dated November 1, 2012 (unaudited).
Investment results assume all distributions are reinvested and reflect applicable fees and expenses. When applicable, investment results reflect fee waivers, without which results would have been lower. Visit americanfunds.com for more information.
Results for other share classes can be found on page 3.
Refer to the fund prospectus and the Risk Factors section of this report for more information on risks associated with investing in the fund.
Fellow investors:
Despite a steady stream of challenging headlines on a range of issues — from European sovereign debt, to growth in China, to fiscal concerns in the U.S. —the stock market climbed the proverbial “wall of worry” and had good returns for the 12 months ended August 31, 2012. There were periods of volatility, but the power of monetary easing by the Federal Reserve, and the strength of good fundamentals for certain individual stocks, overcame these concerns.
During the period, The Growth Fund of America (GFA) posted a total return of 13.1%. On an absolute basis, the return was satisfactory. On a relative basis, the fund trailed the 18.0% return of the unmanaged Standard & Poor’s 500 Composite Index, a broad measure of the U.S. stock market. As shown in the chart below, the fund trailed three of the four Lipper indexes we use to measure GFA’s progress but was in line with the 13.1% average of the four. For added perspective, we note how difficult stock markets were outside the U.S. in this period. The MSCI All Country World Index ex USA returned –1.4%.
Over longer periods, GFA has continued to outpace the S&P 500 and its comparable Lipper peer group indexes by significant margins. For the 10 years ended August 31, 2012, GFA posted an average annual total return of 7.6%, compared with 6.5% by the S&P 500. Over 20 years, GFA produced an average annual total return of 10.3%, compared with 8.4% by the S&P 500. Over its nearly 39-year history, GFA had an average annual total return of 13.3%, compared with 10.5% by the S&P 500. We continue to believe that we have a sound and robust investment approach that can do well for our shareholders over the long term.
[Begin Sidebar]
Results at a glance | | | | | | | | | | | | |
Total returns for periods ended August 31, 2012, with all distributions reinvested | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | Total returns | | | Average annual total returns | |
| | 1 year | | | 5 years | | | 10 years | | | Lifetime1 | |
The Growth Fund of America | | | | | | | | | | | | |
(Class A shares) | | | 13.1 | % | | | 0.4 | % | | | 7.6 | % | | | 13.3 | % |
| | | | | | | | | | | | | | | | |
Standard & Poor’s 500 Composite Index2 | | | 18.0 | | | | 1.3 | | | | 6.5 | | | | 10.5 | |
| | | | | | | | | | | | | | | | |
Lipper Capital Appreciation Funds Index | | | 10.5 | | | | 1.6 | | | | 7.3 | | | | 10.5 | |
| | | | | | | | | | | | | | | | |
Lipper Growth Funds Index | | | 13.6 | | | | 0.4 | | | | 5.6 | | | | 9.4 | |
| | | | | | | | | | | | | | | | |
Lipper Large-Cap Core Funds Index | | | 14.8 | | | | 0.6 | | | | 5.4 | | | | — | 3 |
| | | | | | | | | | | | | | | | |
Lipper Large-Cap Growth Funds Index | | | 13.4 | | | | 1.9 | | | | 5.6 | | | | — | 3 |
| | | | | | | | | | | | | | | | |
1 Since Capital Research and Management Company (CRMC) began managing the fund on December 1, 1973. | | | | | | | | | |
2 The S&P 500 is unmanaged and, therefore, has no expenses. | | | | | | | | | | | | | | | | |
3 This Lipper index was not in existence when CRMC began managing the fund. | | | | | | | | | | | | | | | | |
[End Sidebar]
[photo of peaches hanging from tree branches]
[Begin Sidebar]
In this report | |
| |
| Special feature |
| |
6 | Investing in companies that can do well in any market |
| |
| Contents |
| |
1 | Letter to investors |
| |
4 | The value of a long-term perspective |
| |
12 | Summary investment |
| portfolio |
| |
18 | Financial statements |
| |
35 | Board of directors and other officers |
[End Sidebar]
Investment results analysis
The fund’s 20 largest holdings produced very satisfying results. GFA’s largest investment, Apple, had a total return of 72.9%, aided by rising sales of its iPad and iPhone products. Consumer discretionary stocks that helped were Comcast (+55.7%), the nation’s largest cable television provider, and home improvement retailer Home Depot (+70%).
Health care stocks made a major contribution to the fund over the past 12 months. Gilead Sciences, the fund’s fourth-largest holding, rose 44.6% during the period. Last November, Gilead agreed to acquire Pharmasset, a smaller company that is developing a drug to treat the hepatitis C virus. Pharmasset, also a GFA holding, rose 104.0% from the beginning of the fiscal year to the day when it was announced that a definitive agreement had been reached. In addition, Alexion Pharmaceuticals gained 85%.
GFA’s non-U.S. holdings, which constituted about 14% of net assets, detracted from results during the recent year. In particular, Canadian natural resource, materials and energy companies’ returns declined. They included Canadian Natural Resources (–19.5%) and Potash Corp. of Saskatchewan (–29.2%). Falling natural gas and oil prices hurt these firms. The fund’s investments in China, while relatively small, lagged because of slowing sales. Over most of the past decade, GFA’s international investments have helped the fund. We continue to believe that our investors will benefit in the long run from our involvement in non-U.S. markets because of the advantage of GFA’s extensive global research network.
The fund’s holdings of cash and cash equivalents, which totaled about 9% during the year, also detracted from results in a rising stock market on a relative basis. Many of the fund’s portfolio counselors believed it was prudent to hold some cash in this uncertain environment, a judgment that increases flexibility in the event of volatility and may yet prove to be helpful. Cash is not a top-down decision by the fund but is an aggregate of the views of individual portfolio counselors.
Welcome new portfolio counselors
Two portfolio counselors are leaving GFA at the end of the year and two new portfolio counselors have joined the fund. The new portfolio counselors are Barry Crosthwaite and Martin Romo, both veteran American Funds portfolio counselors. Barry has 15 years of experience with our firm and Martin has 20 years. The exiting counselors are Gordon Crawford, who is retiring at the end of the calendar year (see the box below for more details), and Dylan Yolles, who left the fund in September to take on new investing responsibilities with other American Funds. We thank Gordon and Dylan for their many contributions to GFA over the years.
The road ahead
In the coming months, we can expect to see a repeat of the negative headlines we’ve already been seeing. Sovereign debt problems in Europe and fiscal problems in the U.S. have not been resolved. It is harder to say whether we will continue with good market returns despite the news. The stock market will be looking for whether the trajectory of these issues is improving or not. Flare-ups in the Middle East, as well as developments in the U.S. presidential election, may add to volatility.
As we mention in our feature story, we seek to invest in companies that can do well in almost any environment. Turn to page 6 to see examples of companies in GFA that, in the recent past, have created their own demand or provided relatively recession-resistant services. We invest in stocks one at a time, after extensive, fundamental research. We invest with a long-term horizon at a time when many others have shortened their time frame. We pay close attention to valuation, which can help mitigate risk and increase return. Ours is a durable investment approach that has stood the test of time, and in which we are confident.
We thank you for your support of The Growth Fund of America.
Cordially,
/s/ James F. Rothenberg
James F. Rothenberg
Vice Chairman of the Board
/s/ Donald D. O’Neal
Donald D. O’Neal
President
October 8, 2012
For current information about the fund, visit americanfunds.com.
[Begin Sidebar]
[photo of Gordon Crawford]
We take this opportunity to say special thanks to Gordon Crawford, senior vice president of The Growth Fund of America, who will retire at the end of 2012 after a 40-year career at The Capital Group Companies. Twenty of those years were spent as a portfolio counselor with GFA, but he influenced the fund for all of his lengthy career as either an analyst or counselor. Gordon is a well-known and well-respected investor among the media/entertainment companies and their leaders. We thank him for his uniquely large contributions and long-term dedicated service. We wish him well.
[End Sidebar]
Other share class results
unaudited
Classes B, C, F and 529
Fund results shown are for past periods and are not predictive of results for future periods. Current and future results may be lower or higher than those shown. Share prices and returns will vary, so investors may lose money. For current information and month-end results, visit americanfunds.com.
Average annual total returns for periods ended September 30, 2012 (the most recent calendar quarter-end): | | | | | | | | | |
| | | | | | | | 10 years/ | |
| | 1 year | | | 5 years | | | Life of class1 | |
Class B shares2 | | | | | | | | | |
Reflecting applicable contingent deferred sales charge | | | | | | | | | |
(CDSC), maximum of 5%, payable only if shares | | | | | | | | | |
are sold within six years of purchase | | | 21.96 | % | | | –1.06 | % | | | 8.07 | % |
Not reflecting CDSC | | | 26.96 | | | | –0.69 | | | | 8.07 | |
| | | | | | | | | | | | |
Class C shares | | | | | | | | | | | | |
Reflecting CDSC, maximum of 1%, payable only | | | | | | | | | | | | |
if shares are sold within one year of purchase | | | 25.93 | | | | –0.71 | | | | 7.86 | |
Not reflecting CDSC | | | 26.93 | | | | –0.71 | | | | 7.86 | |
| | | | | | | | | | | | |
Class F-1 shares3 | | | | | | | | | | | | |
Not reflecting annual asset-based fee charged | | | | | | | | | | | | |
by sponsoring firm | | | 27.94 | | | | 0.10 | | | | 8.73 | |
| | | | | | | | | | | | |
Class F-2 shares3 — first sold 8/1/08 | | | | | | | | | | | | |
Not reflecting annual asset-based fee charged | | | | | | | | | | | | |
by sponsoring firm | | | 28.26 | | | | — | | | | 3.74 | |
| | | | | | | | | | | | |
Class 529-A shares4 | | | | | | | | | | | | |
Reflecting 5.75% maximum sales charge | | | 20.50 | | | | –1.16 | | | | 8.05 | |
Not reflecting maximum sales charge | | | 27.87 | | | | 0.02 | | | | 8.69 | |
| | | | | | | | | | | | |
Class 529-B shares2,4 | | | | | | | | | | | | |
Reflecting applicable CDSC, maximum of 5%, payable | | | | | | | | | | | | |
only if shares are sold within six years of purchase | | | 21.82 | | | | –1.15 | | | | 7.95 | |
Not reflecting CDSC | | | 26.82 | | | | –0.78 | | | | 7.95 | |
| | | | | | | | | | | | |
Class 529-C shares4 | | | | | | | | | | | | |
Reflecting CDSC, maximum of 1%, payable only | | | | | | | | | | | | |
if shares are sold within one year of purchase | | | 25.85 | | | | –0.77 | | | | 7.79 | |
Not reflecting CDSC | | | 26.85 | | | | –0.77 | | | | 7.79 | |
| | | | | | | | | | | | |
Class 529-E shares3,4 | | | 27.53 | | | | –0.26 | | | | 8.34 | |
| | | | | | | | | | | | |
Class 529-F-1 shares3,4 | | | | | | | | | | | | |
Not reflecting annual asset-based fee charged | | | | | | | | | | | | |
by sponsoring firm | | | 28.08 | | | | 0.22 | | | | 8.80 | |
| 1Applicable to Class F-2 shares only. All other share classes reflect 10-year results. |
| 2These shares are not available for purchase. |
| 3These shares are sold without any initial or contingent deferred sales charge. |
| 4Results shown do not reflect the $10 account setup fee and an annual $10 account maintenance fee. |
Investment results assume all distributions are reinvested and reflect applicable fees and expenses. When applicable, investment results reflect fee waivers, without which results would have been lower. Visit americanfunds.com for more information.
For information regarding the differences among the various share classes, refer to the fund prospectus.
The value of a long-term perspective
How a $10,000 investment has grown
Fund results shown are for Class A shares and reflect deduction of the maximum sales charge of 5.75% on the $10,000 investment.1 Thus, the net amount invested was $9,425.2 Results are for past periods and are not predictive of results for future periods. Current and future results may be lower or higher than those shown. Share prices and returns will vary, so investors may lose money. For current information and month-end results, visit americanfunds.com.
Average annual total returns based on a $1,000 investment (for periods ended August 31, 2012)* | | | | | | | | | |
| | | | | | | | | |
| | 1 year | | | 5 years | | | 10 years | |
Class A shares | | | 6.59 | % | | | –0.81 | % | | | 6.97 | % |
| | | | | | | | | | | | |
*Assumes reinvestment of all distributions and payment of the maximum 5.75% sales charge. | | | | | | | | | | | | |
Investment results assume all distributions are reinvested and reflect applicable fees and expenses. When applicable, investment results reflect the waivers, without which results would have been lower. Visit americanfunds.com for more information.
[begin mountain chart]
FY END (Aug 31) | | The Growth Fund of America3 | | | Standard & Poor’s 500 Composite Index with dividends reinvested4 | | | Lipper Growth Funds Index5 | | | Consumer Price Index (inflation)6 | |
| | | | | | | | | | | | |
12/1/1973 | | $ | 9,425 | | | $ | 10,000 | | | $ | 10,000 | | | $ | 10,000 | |
8/31/1974# | | | 7,874 | | | | 7,749 | | | | 7,204 | | | | 10,893 | |
8/31/1975 | | | 9,792 | | | | 9,776 | | | | 9,126 | | | | 11,830 | |
8/31/1976 | | | 11,165 | | | | 12,043 | | | | 10,607 | | | | 12,505 | |
8/31/1977 | | | 12,377 | | | | 11,835 | | | | 10,558 | | | | 13,333 | |
8/31/1978 | | | 20,136 | | | | 13,315 | | | | 13,315 | | | | 14,379 | |
8/31/1979 | | | 23,595 | | | | 14,881 | | | | 15,033 | | | | 16,078 | |
8/31/1980 | | | 31,496 | | | | 17,588 | | | | 19,013 | | | | 18,148 | |
8/31/1981 | | | 35,383 | | | | 18,539 | | | | 20,125 | | | | 20,109 | |
8/31/1982 | | | 38,595 | | | | 19,134 | | | | 20,339 | | | | 21,285 | |
8/31/1983 | | | 56,382 | | | | 27,582 | | | | 30,631 | | | | 21,830 | |
8/31/1984 | | | 56,805 | | | | 29,280 | | | | 29,823 | | | | 22,767 | |
8/31/1985 | | | 64,493 | | | | 34,616 | | | | 34,712 | | | | 23,529 | |
8/31/1986 | | | 82,962 | | | | 48,158 | | | | 46,117 | | | | 23,900 | |
8/31/1987 | | | 109,731 | | | | 64,779 | | | | 59,044 | | | | 24,924 | |
8/31/1988 | | | 97,962 | | | | 53,241 | | | | 49,752 | | | | 25,926 | |
8/31/1989 | | | 136,507 | | | | 74,101 | | | | 67,293 | | | | 27,146 | |
8/31/1990 | | | 123,184 | | | | 70,400 | | | | 62,015 | | | | 28,671 | |
8/31/1991 | | | 160,815 | | | | 89,300 | | | | 79,872 | | | | 29,760 | |
8/31/1992 | | | 168,703 | | | | 96,368 | | | | 84,053 | | | | 30,697 | |
8/31/1993 | | | 210,269 | | | | 110,996 | | | | 101,030 | | | | 31,547 | |
8/31/1994 | | | 222,852 | | | | 117,057 | | | | 105,782 | | | | 32,462 | |
8/31/1995 | | | 279,812 | | | | 142,129 | | | | 128,702 | | | | 33,312 | |
8/31/1996 | | | 282,323 | | | | 168,734 | | | | 142,829 | | | | 34,270 | |
8/31/1997 | | | 391,124 | | | | 237,282 | | | | 191,969 | | | | 35,033 | |
8/31/1998 | | | 390,174 | | | | 256,505 | | | | 196,093 | | | | 35,599 | |
8/31/1999 | | | 629,203 | | | | 358,611 | | | | 277,049 | | | | 36,405 | |
8/31/2000 | | | 965,880 | | | | 417,104 | | | | 354,976 | | | | 37,647 | |
8/31/2001 | | | 721,756 | | | | 315,433 | | | | 236,853 | | | | 38,671 | |
8/31/2002 | | | 578,827 | | | | 258,698 | | | | 188,774 | | | | 39,368 | |
8/31/2003 | | | 701,724 | | | | 289,889 | | | | 214,778 | | | | 40,218 | |
8/31/2004 | | | 762,451 | | | | 323,073 | | | | 227,211 | | | | 41,285 | |
8/31/2005 | | | 924,112 | | | | 363,626 | | | | 261,043 | | | | 42,789 | |
8/31/2006 | | | 1,013,358 | | | | 395,887 | | | | 277,109 | | | | 44,423 | |
8/31/2007 | | | 1,182,434 | | | | 455,775 | | | | 320,863 | | | | 45,298 | |
8/31/2008 | | | 1,085,043 | | | | 405,029 | | | | 284,553 | | | | 47,731 | |
8/31/2009 | | | 894,135 | | | | 331,128 | | | | 228,567 | | | | 47,023 | |
8/31/2010 | | | 922,764 | | | | 347,454 | | | | 241,543 | | | | 47,563 | |
8/31/2011 | | | 1,065,029 | | | | 411,656 | | | | 287,751 | | | | 49,356 | |
8/31/2012 | | | 1,204,303 | | | | 485,670 | | | | 327,029 | | | | 50,192 | |
[end mountain chart]
Year ended August 31 | | | 1974 | 7 | | | 1975 | | | | 1976 | | | | 1977 | | | | 1978 | | | | 1979 | | | | 1980 | | | | 1981 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total value (dollars in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends reinvested | | | — | | | $ | .4 | | | | .3 | | | | — | | | | .3 | | | | — | | | | .3 | | | | .5 | |
Value at year-end | | $ | 7.9 | | | | 9.8 | | | | 11.2 | | | | 12.4 | | | | 20.1 | | | | 23.6 | | | | 31.5 | | | | 35.4 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GFA total return | | | (21.3 | %) | | | 24.4 | | | | 14.0 | | | | 10.9 | | | | 62.7 | | | | 17.2 | | | | 33.5 | | | | 12.3 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended August 31 | | | 1982 | | | | 1983 | | | | 1984 | | | | 1985 | | | | 1986 | | | | 1987 | | | | 1988 | | | | 1989 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total value (dollars in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends reinvested | | | 1.7 | | | | 2.3 | | | | 1.6 | | | | 1.2 | | | | 1.0 | | | | 1.4 | | | | 1.5 | | | | 1.7 | |
Value at year-end | | | 38.6 | | | | 56.4 | | | | 56.8 | | | | 64.5 | | | | 83.0 | | | | 109.7 | | | | 98.0 | | | | 136.5 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GFA total return | | | 9.1 | | | | 46.1 | | | | 0.8 | | | | 13.5 | | | | 28.6 | | | | 32.3 | | | | (10.7 | ) | | | 39.3 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended August 31 | | | 1990 | | | | 1991 | | | | 1992 | | | | 1993 | | | | 1994 | | | | 1995 | | | | 1996 | | | | 1997 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total value (dollars in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends reinvested | | | 3.6 | | | | 3.2 | | | | 2.5 | | | | 1.5 | | | | .9 | | | | 1.4 | | | | 2.5 | | | | 2.0 | |
Value at year-end | | | 123.2 | | | | 160.8 | | | | 168.7 | | | | 210.3 | | | | 222.9 | | | | 279.8 | | | | 282.3 | | | | 391.1 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GFA total return | | | (9.8 | ) | | | 30.5 | | | | 4.9 | | | | 24.6 | | | | 6.0 | | | | 25.6 | | | | 0.9 | | | | 38.5 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended August 31 | | | 1998 | | | | 1999 | | | | 2000 | | | | 2001 | | | | 2002 | | | | 2003 | | | | 2004 | | | | 2005 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total value (dollars in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends reinvested | | | 2.5 | | | | 2.0 | | | | 1.1 | | | | 3.9 | | | | 1.4 | | | | .6 | | | | .2 | | | | 2.8 | |
Value at year-end | | | 390.2 | | | | 629.2 | | | | 965.9 | | | | 721.8 | | | | 578.8 | | | | 701.7 | | | | 762.5 | | | | 924.1 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GFA total return | | | (0.2 | ) | | | 61.3 | | | | 53.5 | | | | (25.3 | ) | | | (19.8 | ) | | | 21.2 | | | | 8.7 | | | | 21.2 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended August 31 | | | 2006 | | | | 2007 | | | | 2008 | | | | 2009 | | | | 2010 | | | | 2011 | | | | 2012 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total value (dollars in thousands) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends reinvested | | | 5.9 | | | | 8.7 | | | | 11.9 | | | | 8.3 | | | | 7.6 | | | | 8.09 | | | | 8.0 | | | | | |
Value at year-end | | | 1,013.4 | | | | 1,182.4 | | | | 1,085.0 | | | | 894.1 | | | | 922.8 | | | | 1,065.0 | | | | 1,204.3 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GFA total return | | | 9.7 | | | | 16.7 | | | | (8.2 | ) | | | (17.6 | ) | | | 3.2 | | | | 15.4 | | | | 13.1 | | | | | |
Average annual total return for 38-3/4 years 13.2%3
| 1As outlined in the prospectus, the sales charge is reduced for accounts (and aggregated investments) of $25,000 or more and is eliminated for purchases of $1 million or more. There is no sales charge on dividends or capital gain distributions that are reinvested in additional shares. |
| 2The maximum initial sales charge was 8.5% prior to July 1, 1988. |
| 3Includes reinvested dividends of $105,406 and reinvested capital gain distributions of $479,731. |
| 4The S&P 500 is unmanaged and, therefore, has no expenses. |
| 5Results of the Lipper Growth Funds Index do not reflect any sales charges. |
| 6Computed from data supplied by the U.S. Department of Labor, Bureau of Labor Statistics. |
| 7For the period December 1, 1973 (when Capital Research and Management Company became the fund’s investment adviser), through August 31, 1974. |
The results shown are before taxes on fund distributions and sale of fund shares.
Investing in companies that can do well in any market
One goal of GFA’s portfolio counselors and analysts is to find companies that have pricing power and whose products can create their own demand.
[photo of a woman standing next to a wooden bucket of peaches on a ladder - a peach in her hand]
[Begin Photo Caption]
[photo of Don O’Neal]
Don O’Neal
“Whether the environment is improving or not, our mission is to find attractively priced, fundamentally sound companies in which to invest.”
President of the fund
[End Photo Caption]
Investors faced plenty of unsettling headlines in the past year. Top of the list were the myriad troubles in Europe, including the potential breakup of the euro zone. In the U.S., the economy remains slow, the government is headed toward a “fiscal cliff,” the presidential election adds uncertainty and we’re even having major droughts affecting crops. Other large economies, like China and Brazil, appear to be slowing down. Despite all this, along with bouts of volatility, the U.S. stock market continued to climb the proverbial “wall of worry” the past 12 months. From August 31, 2011, to August 31, 2012, Standard & Poor’s 500 Composite Index, a broad measure of the U.S. stock market, gained 18%, which illustrates the difficulty of predicting the market in the short term.
The Growth Fund of America’s professional investors monitor these developments very closely with a worldwide investment network. “Whether the environment is improving or not, our mission is to find attractively priced, fundamentally sound companies in which to invest,” says Don O’Neal, president of GFA. “With a long-term horizon, it is often easiest to find them when the headlines are bad.”
In the following pages, we talk with several of GFA’s investment professionals who focus on companies they believe have the potential to do well in the coming years, even if some of the negative news continues to rattle stock markets. Here are several examples of those companies.
Companies with products that generate their own demand
One goal of GFA’s portfolio counselors and analysts is to find companies that have pricing power and whose products can create their own demand. GFA investment analyst Jay Markowitz, M.D., a specialist in biotechnology and pharmaceutical stocks, contends that “novel drugs for serious unmet medical needs fit that mandate.”
Jay came into investing from a career as a transplant surgeon at Johns Hopkins Medical Center in Baltimore where he was a member of the medical faculty. “I spent a fair amount of my career taking care of people who have suffered the ravages of hepatitis C, so I know it very well,” says Jay. “I have witnessed the consequences of liver disease and appreciate the dramatic advances that have now occurred and that have the potential to eradicate this disease.”
Hepatitis C, a virus that causes inflammation of the liver, affects more than 150 million people worldwide, according to estimates from the World Health Organization. The Centers for Disease Control and Prevention estimates that about 3 million people in the United States are infected. As many as three-quarters of them may not even know that they are infected, says Jay.
[photo of peaches hanging from tree branches]
[Begin Photo Caption]
[photo of Jim Rothenberg]
Jim Rothenberg
“For me, investing is about finding companies that create wealth by growing over time and producing a stream of earnings and dividends. Stock markets rise and fall for a host of reasons, but great companies can continue to make progress often in difficult economic environments.”
Vice chairman of the fund
[End Photo Caption]
[Begin Photo Caption]
[photo of Jay Markowitz]
Jay Markowitz, M.D.
“I’ve found that drug companies with transformational therapies have often offered positive returns regardless of what the broader stock market is doing.”
Investment analyst, biotechnology and pharmaceuticals
[End Photo Caption]
[photo of wooden boxes of peaches]
Several pharmaceutical companies are developing treatments for hepatitis C and have made some progress in recent years in reducing the length of treatment from 48 weeks to 24 weeks. Cure rates have been improved from 45% to somewhere between 70% and 80%, depending on the patient’s condition when diagnosed, says Jay. But the drugs still can have serious side effects depending on the individual.
Gilead Sciences, one of GFA’s largest holdings, is striving to improve the treatment of hepatitis C as it has successfully done with HIV (human immunodeficiency virus; a retrovirus that causes AIDS). In January 2012, Gilead Sciences acquired Pharmasset, a company entering the final phase of testing a promising drug for hepatitis C. Gilead Sciences is hopeful that it will become the key ingredient in an effective, safe and convenient pill that cures people of their infection.
Does Gilead have the potential to create its own demand for its medicines? “I’ve found that drug companies with transformational therapies have often offered positive returns regardless of what the broader stock market is doing,” says Jay.
[Begin Photo Caption]
[photo of Brad Barrett]
Brad Barrett
“I try to meet deep down in the organization with the operators of various business units, strategy
advisers and technology experts.”
Investment analyst, media
[End Photo Caption]
Companies with products that are recession-resistant
In the highly competitive media market, Comcast, one of the largest providers of cable television and internet services, has been in a position of strength that has allowed the company to do relatively well despite the environment. The Philadelphia-based company sells a bundle of video, broadband and phone services and merged in 2011 with NBC Universal to give it entertainment content as well.
Brad Barrett, an investment analyst who covers media companies, sees three major reasons for the company’s historically strong position. “The first is that cable television and internet access are essential to the lives of many of its customers. Cable TV and cable broadband are some of the very last things to be cut during hard times.” In fact, Comcast grew right through the recession of 2008 and 2009. The second reason is that “Comcast has generated a lot of cash and returned much of it to shareholders in dividends and share buybacks,” says Brad.
[photo of a peach hanging from a tree branch]
The third reason is that Comcast has tended to trade at a valuation that is lower than the typical company, which tends to provide downside protection in volatile markets.
How does Brad research such a complex media company? He visits company headquarters and meets with the management team multiple times a year. Brad also attends industry events. “I try to meet deep down in the organization with the operators of various business units, strategy advisers and technology experts. It is also important that I meet regularly with their competitors, like DirecTV and Netflix, in order to have a deep understanding of the industry.”
[photo of a peach tree]
[Begin Sidebar]
A wealth of experience | |
| |
The Growth Fund of America currently has 13 portfolio counselors who bring together 391 years of investment experience to managing your investment. Here are the specific years of experience for these primary decision-makers for the fund.* |
| |
| Years of investment |
Portfolio counselor | experience* |
Ronald B. Morrow | 44 |
James F. Rothenberg | 41 |
Gordon Crawford† | 40 |
James E. Drasdo | 40 |
Gregg E. Ireland | 40 |
Donnalisa Barnum | 30 |
Michael T. Kerr | 28 |
Donald D. O’Neal | 26 |
Carl M. Kawaja | 25 |
Bradley J. Vogt | 24 |
Martin Romo | 20 |
J. Blair Frank | 18 |
Barry Crosthwaite | 15 |
| |
*As of August 31, 2012. | |
†Until November 30, 2012. | |
[End Sidebar]
[Begin Photo Caption]
[photo of Craig Gordon]
Craig Gordon, M.D.
“Most people don’t understand the global power of drugs for rare diseases. There are 7,000 rare diseases and only a fraction have treatments.”
Investment analyst, pharmaceuticals
[End Photo Caption]
[Begin Sidebar]
Companies that have pricing power
Alexion Pharmaceuticals, the fund’s 20th largest holding, specializes in developing treatments for severe, rare diseases that, at most, affect one out of every 50,000 people.
The company’s leading drug so far is Soliris®, which treats a rare type of anemia. Compensating for the small market of 5,000 to 10,000 patients in the U.S., and a similar number in Great Britain, is the fact that there are no other treatments. The drug thus has pricing power because it solves a health problem that no one else has been able to solve. “The drug is curative for a very rare and devastating disease and it has been reimbursed by insurance companies in the U.S., Europe, Australia and Japan,” says investment analyst Craig Gordon, M.D. “Most people don’t understand the global power of drugs for rare diseases. There are 7,000 rare diseases and only a fraction have treatments.” In 2012, Soliris is expected to produce more than $1.1 billion in revenue.
Craig is well-trained for analyzing complex drugs and how they react to patients with rare diseases. After graduating from medical school, he practiced general medicine for three years and then spent two years as a specialist in rheumatology. With a lifelong interest in investing instilled by his father, he decided to go to business school to get his MBA. To pay for it, he worked nights and weekends as an emergency room physician.
He says there are definite advantages for an investment analyst who specializes in pharmaceuticals to have actually practiced medicine. “You understand the mentality of the average physician and the typical patient. You learn how insurance companies think and which procedures and drugs they will likely reimburse, and which stand less of a chance.”
[End Sidebar]
[photo of peaches]
Companies that can attract more business by improving their customer service
“If you look over the past few years beginning in 2007, the housing market has been in the doldrums, yet Home Depot, the nation’s largest home improvement retailer, has been doing relatively well,” says Jessica Spaly, an investment analyst who specializes in retail companies.
The slow housing market has played into the company’s favor, leading more homeowners to consider repairs and home renovations rather than moving to new homes. Even as the housing market improves, it could benefit Home Depot further as contractors and construction firms go there for supplies.
“Home Depot has migrated from a decentralized, large firm to a centralized company that leverages the latest practices in technology and improvements in the supply chain,” says Jessica. “Store associates now have handheld tools that tell them exactly where inventory is located, so they can spend less time looking for items and more time helping customers. Inventory is now mostly ordered centrally using algorithms driven off sales patterns rather than at the store level by employees using their own judgment. This leads to more accurate ordering and, importantly, frees up store associates from ordering products to assisting clients.”
[Begin Photo Caption]
[photo of Anne-Marie Peterson]
Anne-Marie Peterson
“lululemon athletica is an example of a small women’s apparel company that grew to be large through many different market environments.”
Investment analyst, retail
[End Photo Caption]
In Home Depot’s 2011 annual report, Frank Blake, the company’s chief executive officer, wrote that by the end of fiscal 2011 the company had increased the percentage of its employee time allocated to customer service to about 53%, up from 40% four years ago. He said that the company is on track to reach its goal of having 60% of store labor dedicated to helping customers by the end of 2013.
Jessica, who is based in San Francisco, says an important part of her job covering Home Depot is visiting stores to monitor if management’s statements are being followed at the store level. “With the location of Home Depot stores in metropolitan areas throughout the U.S., you can see the company in action anytime you want.”
Small companies can grow to large companies, even in a difficult environment
“lululemon athletica is an example of a small women’s apparel company that grew to be large through many different market environments,” says Anne-Marie Peterson, also an investment analyst in retail companies. lululemon began in Vancouver, British Columbia, as a yoga athletic apparel company in a small shop in 1998. It was created by Dennis “Chip” Wilson in response to increased female participation in sports and in accordance with his belief in yoga as the optimal way to maintain athletic excellence into an advanced age.
The company evolved from simply making yoga clothing to making yoga apparel a fashion statement. “When you create the market, the company can experience powerful growth,” says Anne-Marie. “lululemon has taken boring athletic apparel and made it look appealing and compelling.”
It was a game changer. The company went public in 2007 and stores spread from its birthplace in Canada to the United States. “In the past, yoga apparel was a commodity purchase and today it is a fashion purchase,” says Anne-Marie. “It has moved into the sweet spot of consumer preferences. Today you can wear your trendy yoga pants to the grocery store after your workout and stand out because of the styling.” n
[photo of a wooden bucket of peaches and a ladder under a peach tree]
[Begin Photo Caption]
[photo of Jessica Spaly]
Jessica Spaly
“If you look over the past few years beginning in 2007, the housing market has been in the doldrums, yet Home Depot, the nation’s largest home improvement retailer, has been doing relatively well.”
Investment analyst, retail
[End Photo Caption]
Approval of Investment Advisory and Service Agreement
The fund’s board has approved the fund’s Investment Advisory and Service Agreement (the “agreement”) with Capital Research and Management Company (“CRMC”) for an additional one-year term through November 30, 2013. The board approved the agreement following the recommendation of the fund’s Contracts Committee (the “committee”), which is composed of all of the fund’s independent board members. The board and the committee determined that the fund’s advisory fee structure was fair and reasonable in relation to the services provided and that approving the agreement was in the best interests of the fund and its shareholders.
In reaching this decision, the board and the committee took into account information furnished to them throughout the year, as well as information prepared specifically in connection with their review of the agreement and were advised by their independent counsel. They considered the factors discussed below, among others, but did not identify any single issue or particular piece of information that, in isolation, was the controlling factor.
1. Nature, extent and quality of services
The board and the committee considered the depth and quality of CRMC’s investment management process, including its global research capabilities; the experience, capability and integrity of its senior management and other personnel; the low turnover rates of its key personnel; the overall financial strength and stability of its organization; and the ongoing evolution of CRMC’s organizational structure designed to maintain and strengthen these qualities. The board and the committee also considered the nature, extent and quality of administrative, compliance and shareholder services provided by CRMC to the fund under the agreement and other agreements as well as the benefits to fund shareholders from investing in a fund that is part of a large family of funds. The board and the committee concluded that the nature, extent and quality of the services provided by CRMC have benefited and should continue to benefit the fund and its shareholders.
2. Investment results
The board and the committee considered the investment results of the fund in light of its objective of providing growth of capital. They compared the fund’s total returns with those of other relevant funds (including the other funds that are the basis of the Lipper index for the category in which the fund is included) and market data such as relevant market indices, in each case as available at the time of the related board and committee meetings. This report, including the letter to shareholders and related disclosures, contains certain information about the fund’s investment results. The board and the committee concluded that the fund’s long-term results have been satisfactory and that CRMC’s record in managing the fund indicated that its continued management should benefit the fund and its shareholders.
3. Advisory fees and total expenses
The board and the committee compared the advisory fees and total expense levels of the fund to those of other relevant funds. They observed that the fund’s advisory fees and expenses remain significantly below those of most other relevant funds. The board and the committee also noted the breakpoint discounts in the fund’s advisory fee structure that reduce the level of fees charged by CRMC to the fund as fund assets increase. In addition, they reviewed information regarding the advisory fees paid by clients of an affiliate of CRMC. They noted that, to the extent there were differences between the advisory fees paid by the fund and the advisory fees paid by those clients, the differences appropriately reflected the investment, operational and regulatory differences between advising the fund and the other clients. The board and the committee concluded that the fund’s cost structure was fair and reasonable in relation to the services provided, and that the shareholders receive reasonable value in return for the advisory fees and other amounts paid to CRMC by the fund.
4. Ancillary benefits
The board and the committee considered a variety of other benefits received by CRMC and its affiliates as a result of CRMC’s relationship with the fund and the other American Funds, including fees for administrative services provided to certain share classes; fees paid to CRMC’s affiliated transfer agent; sales charges and distribution fees received and retained by the fund’s principal underwriter, an affiliate of CRMC; and possible ancillary benefits to CRMC’s institutional management affiliates. The board and the committee reviewed CRMC’s portfolio trading practices, noting that while CRMC receives the benefit of research provided by broker-dealers executing portfolio transactions on behalf of the fund, it does not obtain third-party research or other services in return for allocating brokerage to such broker-dealers. The board and the committee took these ancillary benefits into account in evaluating the reasonableness of the advisory fees and other amounts paid to CRMC by the fund.
5. Adviser financial information
The board and the committee reviewed information regarding CRMC’s costs of providing services to the American Funds, including personnel, systems and resources of investment, compliance, trading, accounting and other administrative operations. They considered CRMC’s costs and willingness to invest in technology, infrastructure and staff to maintain and expand services and capabilities, respond to industry and regulatory developments and attract and retain qualified personnel. They noted information regarding the compensation structure for CRMC’s investment professionals. The board and the committee also compared CRMC’s profitability to the reported results of several large, publicly held investment management companies. The board and the committee noted the competitiveness and cyclicality of both the mutual fund industry and the capital markets, and the importance in that environment of CRMC’s long-term profitability for maintaining its independence, company culture and management continuity. They further considered the breakpoint discounts in the fund’s advisory fee structure. The board and the committee concluded that the fund’s advisory fee structure reflected a reasonable sharing of benefits between CRMC and the fund’s shareholders.
Board of directors and other officers
“Independent” directors1 | | |
| Year first | |
| elected a | |
| director of | |
Name and age | the fund2 | Principal occupation(s) during past five years |
| | |
Ronald P. Badie, 69 | 2008 | Retired; former Vice Chairman, Deutsche Bank Alex. |
| | Brown |
| | |
Joseph C. Berenato, 66 | 2003 | Former Chairman and CEO, Ducommun Incorporated |
Chairman of the Board | | (aerospace components manufacturer) |
(Independent and | | |
Non-Executive) | | |
| | |
Louise H. Bryson, 68 | 2008 | Chair Emerita of the Board of Trustees, J. Paul Getty |
| | Trust; former President, Distribution, Lifetime |
| | Entertainment Network; former Executive Vice |
| | President and General Manager, Lifetime Movie |
| | Network |
| | |
Robert J. Denison, 71 | 2005 | Chair, First Security Management (private investment) |
| | |
Mary Anne Dolan, 65 | 2010 | Founder and President, MAD Ink (communications |
| | company) |
| | |
Robert A. Fox, 75 | 1970 | Managing General Partner, Fox Investments LP; |
| | corporate director |
| | |
John G. Freund, 58 | 2010 | Founder and Managing Director, Skyline Ventures |
| | (venture capital investor in health care companies) |
| | |
Leonade D. Jones, 64 | 1993 | Retired; former Treasurer, The Washington Post |
| | Company |
| | |
William H. Kling, 70 | 2010 | President Emeritus, American Public Media |
| | |
John G. McDonald, 75 | 1976 | Stanford Investors Professor, Graduate School of |
| | Business, Stanford University |
| | |
Christopher E. Stone, 56 | 2010 | President, Open Society Foundations; former |
| | Professor of the Practice of Criminal Justice, John F. |
| | Kennedy School of Government, Harvard University |
| | |
| | |
“Independent” directors1 | | |
| Number of | |
| portfolios | |
| in fund | |
| complex3 | |
| overseen by | |
Name and age | director | Other directorships4 held by director |
| | |
Ronald P. Badie, 69 | 3 | Amphenol Corporation; Nautilus, Inc.; |
| | Obagi Medical Products, Inc. |
| | |
Joseph C. Berenato, 66 | 6 | None |
Chairman of the Board | | |
(Independent and | | |
Non-Executive) | | |
| | |
Louise H. Bryson, 68 | 7 | None |
| | |
Robert J. Denison, 71 | 6 | None |
| | |
Mary Anne Dolan, 65 | 10 | None |
| | |
Robert A. Fox, 75 | 9 | None |
| | |
John G. Freund, 58 | 3 | Mako Surgical Corporation; XenoPort, Inc. |
| | |
Leonade D. Jones, 64 | 9 | None |
| | |
William H. Kling, 70 | 10 | None |
| | |
John G. McDonald, 75 | 13 | iStar Financial, Inc.; Plum Creek Timber Co.; |
| | QuinStreet, Inc.; Scholastic Corporation |
| | |
Christopher E. Stone, 56 | 6 | None |
“Interested” directors5,7 | | |
| Year first | |
| elected a | |
| director or | Principal occupation(s) during past five years |
Name, age and | officer of | and positions held with affiliated entities or the |
position with fund | the fund2 | principal underwriter of the fund |
| | |
James F. Rothenberg, 66 | 1997 | Chairman of the Board, Capital Research and |
Vice Chairman of the Board | | Management Company; Director and Non-Executive |
| | Chairman, American Funds Distributors, Inc.;6 |
| | Director and Non-Executive Chair, The Capital Group |
| | Companies, Inc.6 |
| | |
Donald D. O’Neal, 52 | 1995 | Senior Vice President — Capital Research Global |
President | | Investors, Capital Research and Management |
| | Company; Director, Capital Research and |
| | Management Company |
| | |
| | |
“Interested” directors5,7 | | |
| Number of | |
| portfolios in | |
| fund complex3 | |
Name, age and | overseen | |
position with fund | by director | Other directorships4 held by director |
| | |
James F. Rothenberg, 66 | 2 | None |
Vice Chairman of the Board | | |
| | |
Donald D. O’Neal, 52 | 21 | None |
President | | |
The fund’s statement of additional information includes further details about fund directors and is available without charge upon request by calling American Funds Service Company at 800/421-4225 or by visiting the American Funds website at americanfunds.com. The address for all directors and officers of the fund is 333 South Hope Street, Los Angeles, CA 90071, Attention: Secretary.
See page 36 for footnotes.
Other officers7 | | |
| Year first | |
| elected | Principal occupation(s) during past five years |
Name, age and | an officer | and positions held with affiliated entities or the |
position with fund | of the fund2 | principal underwriter of the fund |
| | |
Michael T. Kerr, 53 | 1998 | Senior Vice President — Capital World Investors, |
Executive Vice President | | Capital Research and Management Company; |
| | Director, Capital Research and Management |
| | Company |
| | |
Paul F. Roye, 58 | 2012 | Senior Vice President — Fund Business Management |
Executive Vice President | | Group, Capital Research and Management Company; |
| | Director, American Funds Service Company;6 former |
| | Director, Division of Investment Management, United |
| | States Securities and Exchange Commission |
| | |
Gordon Crawford, 65 | 1992 | Senior Vice President — Capital Research Global |
Senior Vice President | | Investors, Capital Research and Management |
| | Company |
| | |
Gregg E. Ireland, 62 | 2008 | Senior Vice President — Capital World Investors, |
Senior Vice President | | Capital Research and Management Company |
| | |
Bradley J. Vogt, 47 | 1999 | Director, Capital Research and Management |
Senior Vice President | | Company; Chairman, Capital Research Company;6 |
| | Senior Vice President — Capital Research Global |
| | Investors, Capital Research Company;6 Director, |
| | American Funds Distributors, Inc.6 |
| | |
Brad A. Barrett, 34 | 2010 | Vice President — Capital Research Global Investors, |
Vice President | | Capital Research Company6 |
| | |
Walter R. Burkley, 46 | 2010 | Senior Vice President and Senior Counsel — Fund |
Vice President | | Business Management Group, Capital Research and |
| | Management Company |
| | |
Barry S. Crosthwaite, 54 | 2010 | Senior Vice President — Capital Research Global |
Vice President | | Investors, Capital Research Company;6 Director, |
| | American Funds Service Company6 |
| | |
Martin Romo, 45 | 2010 | Director, Capital Research and Management |
Vice President | | Company; Senior Vice President — Capital World |
| | Investors, Capital Research Company;6 Director and |
| | Co-President, Capital Research Company6 |
| | |
Patrick F. Quan, 54 | 1986–1998 | Vice President — Fund Business Management |
Secretary | 2000 | Group, Capital Research and Management Company |
| | |
Jeffrey P. Regal, 41 | 2006 | Vice President — Fund Business Management |
Treasurer | | Group, Capital Research and Management Company |
| | |
Julie E. Lawton, 39 | 2010 | Assistant Vice President — Fund Business |
Assistant Secretary | | Management Group, Capital Research and |
| | Management Company |
| | |
Dori Laskin, 61 | 2011 | Vice President — Fund Business Management |
Assistant Treasurer | | Group, Capital Research and Management Company |
| | |
Neal F. Wellons, 41 | 2010 | Vice President — Fund Business Management |
Assistant Treasurer | | Group, Capital Research and Management Company |
| 1The term “independent” director refers to a director who is not an “interested person” of the fund within the meaning of the Investment Company Act of 1940. |
| 2Directors and officers of the fund serve until their resignation, removal or retirement. |
| 3Capital Research and Management Company manages the American Funds. Capital Research and Management Company also manages American Funds Insurance Series,® which is composed of 19 funds and serves as the underlying investment vehicle for certain variable insurance contracts; American Funds Target Date Retirement Series,® which is composed of 10 funds and is available through tax-deferred retirement plans and IRAs; American Funds Portfolio Series,SM which is composed of eight funds; and American Funds College Target Date Series,SM which is composed of seven funds. |
| 4This includes all directorships (other than those in the American Funds or other funds managed by Capital Research and Management Company) that are held by each director as a trustee or director of a public company or a registered investment company. |
| 5“Interested persons” within the meaning of the Investment Company Act of 1940, on the basis of their affiliation with the fund’s investment adviser, Capital Research and Management Company, or affiliated entities (including the fund’s principal underwriter). |
| 6Company affiliated with Capital Research and Management Company. |
| 7All of the officers listed, except Mr. Barrett, are officers and/or directors/trustees of one or more of the other funds for which Capital Research and Management Company serves as investment adviser. |
Office of the fund
One Market
Steuart Tower, Suite 2000
Mailing address: P.O. Box 7650
San Francisco, CA 94120-7650
Investment adviser
Capital Research and Management Company
333 South Hope Street
Los Angeles, CA 90071-1406
6455 Irvine Center Drive
Irvine, CA 92618
Transfer agent for shareholder accounts
American Funds Service Company
(Write to the address near you.)
P.O. Box 6007
Indianapolis, IN 46206-6007
P.O. Box 2280
Norfolk, VA 23501-2280
Custodian of assets
State Street Bank and Trust Company
One Lincoln Street
Boston, MA 02111
Counsel
K&L Gates LLP
Four Embarcadero Center, Suite 1200
San Francisco, CA 94111-5994
Independent registered public accounting firm
Deloitte & Touche LLP
695 Town Center Drive
Suite 1200
Costa Mesa, CA 92626-7188
Principal underwriter
American Funds Distributors, Inc.
333 South Hope Street
Los Angeles, CA 90071-1406
Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectus and summary prospectus, which can be obtained from your financial professional and should be read carefully before investing. You may also call American Funds Service Company (AFS) at 800/421-4225 or visit the American Funds website at americanfunds.com.
“American Funds Proxy Voting Procedures and Principles” — which describes how we vote proxies relating to portfolio securities — is available on the American Funds website or upon request by calling AFS. The fund files its proxy voting record with the U.S. Securities and Exchange Commission (SEC) for the 12 months ended June 30 by August 31. The proxy voting record is available free of charge on the SEC website at sec.gov and on the American Funds website.
A complete August 31, 2012, portfolio of The Growth Fund of America’s investments is available free of charge by calling AFS or visiting the SEC website (where it is part of Form N-CSR).
The Growth Fund of America files a complete list of its portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. This filing is available free of charge on the SEC website. You may also review or, for a fee, copy this filing at the SEC’s Public Reference Room in Washington, D.C. Additional information regarding the operation of the Public Reference Room may be obtained by calling the SEC’s Office of Investor Education and Advocacy at 800/SEC-0330. Additionally, the list of portfolio holdings is available by calling AFS.
This report is for the information of shareholders of The Growth Fund of America, but it also may be used as sales literature when preceded or accompanied by the current prospectus or summary prospectus, which gives details about charges, expenses, investment objectives and operating policies of the fund. If used as sales material after December 31, 2012, this report must be accompanied by an American Funds statistical update for the most recently completed calendar quarter.
The American Funds difference
Since 1931, American Funds has helped investors pursue long-term investment success. Our consistent approach — in combination with a proven system — has resulted in a superior long-term track record.
Consistent approach
We base our decisions on a long-term perspective because we believe it is the best way to achieve superior long-term investment results. Our portfolio counselors average 25 years of investment experience, including 21 years at our company, reflecting a career commitment to our long-term approach.1
Proven system
Our system combines individual accountability with teamwork. Each fund is divided into portions that are managed by investment professionals with varied backgrounds, ages and investment styles. An extensive global research effort is the backbone of our system.
Superior long-term track record
Our equity funds have beaten their Lipper peer indexes in 91% of 10-year periods and 96% of 20-year periods. Our fixed-income funds have beaten their Lipper indexes in 60% of 10-year periods and 67% of 20-year periods.2 Our fund management fees have been among the lowest in the industry.3
| 2Based on Class A share results for periods through 12/31/11. Periods covered are the shorter of the fund’s lifetime or since the comparable Lipper index inception date. |
| 3Based on management fees for the 20-year period ended 12/31/11 |
| versus comparable Lipper categories, excluding funds of funds. |
American Funds span a range of investment objectives
| The Growth Fund of America® |
| Capital World Growth and Income Fund® |
| International Growth and Income FundSM |
| The Investment Company of America® |
| Washington Mutual Investors FundSM |
| The Income Fund of America® |
| American Funds Global Balanced FundSM |
| American Funds Mortgage Fund® |
| American High-Income Trust® |
| The Bond Fund of America® |
| Intermediate Bond Fund of America® |
| Short-Term Bond Fund of America® |
| U.S. Government Securities Fund® |
| American Funds Short-Term Tax-Exempt Bond Fund® |
| American High-Income Municipal Bond Fund® |
| Limited Term Tax-Exempt Bond Fund of America® |
| The Tax-Exempt Bond Fund of America® |
| State-specific tax-exempt funds |
| American Funds Tax-Exempt Fund of New York® |
| The Tax-Exempt Fund of California® |
| The Tax-Exempt Fund of Maryland® |
| The Tax-Exempt Fund of Virginia® |
| American Funds Money Market Fund® |
| •American Funds Portfolio SeriesSM |
| American Funds Global Growth PortfolioSM |
| American Funds Growth PortfolioSM |
| American Funds Growth and Income PortfolioSM |
| American Funds Balanced PortfolioSM |
| American Funds Income PortfolioSM |
| American Funds Tax-Advantaged Income PortfolioSM |
| American Funds Preservation PortfolioSM |
| American Funds Tax-Exempt Preservation PortfolioSM |
| •American Funds Target Date Retirement Series® |
| •American Funds College Target Date SeriesSM |
The Capital Group Companies
American Funds Capital Research and Management Capital International Capital Guardian Capital Bank and Trust
Lit. No. MFGEAR-905-1012P
Litho in USA AGD/Q/8057-S33526
Printed on paper containing 10% post-consumer waste
Printed with inks containing soy and/or vegetable oil
ITEM 2 – Code of Ethics